Lila Bio appoints Kimberly Ma as Chief Development Officer

Lila Bio has appointed Kimberly Ma as its Chief Development Officer. Ma brings over two decades of oncology drug development experience, including leadership roles at Abdera Therapeutics and RayzeBio.